Steve Cohen sold CVS Health Corp (NYSE: CVS)
Steve Cohen (D-TN), a U.S. Representative, has disclosed 1 trade in CVS Health Corp (CVS) since 2018, a single sale, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Steve Cohen sold $15,001 - $50,000 of CVS Health Corp (NYSE: CVS) on December 27, 2018. Since that trade, CVS is up +107.19% against the S&P 500 up +227.87%, an outperformance of -120.68%.
Data updated
Steve Cohen's CVS trades vs the price
CVS is up +107.19% since Steve Cohen sold on December 27, 2018, versus +227.87% for the S&P 500.
Performance since this trade
All Steve Cohen CVS trades
Steve Cohen & CVS trading FAQ
Is it legal for Steve Cohen to trade CVS Health Corp (CVS) stock?
Yes. Members of Congress are allowed to trade individual stocks, including CVS Health Corp (CVS), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Steve Cohen sell CVS?
Steve Cohen disclosed a sale of $15,001 - $50,000 of CVS Health Corp (CVS) on December 27, 2018, according to public STOCK Act filings.
How has CVS performed since Steve Cohen's trade?
Since Steve Cohen sold CVS on December 27, 2018, the stock is up +107.19%, versus +227.87% for the S&P 500 over the same period, an outperformance of -120.68%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional CVS trades?
Quantellect tracks every disclosed congressional trade in CVS Health Corp (CVS) on the CVS Health Corp congressional trading page, which aggregates filings across all members of Congress.
Steve Cohen's CVS tradesAll congressional filings for CVS Health CorpSteve Cohen's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.